Cargando…

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System

Virus-like particles (VLPs) derived from viral nucleocapsids are an important class of nanoparticles. The structure, uniformity, stability, and function of these VLPs have attracted scientists in utilizing them as a unique tool in various applications in biomedical fields. Their interaction with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohsen, Mona O., Gomes, Ariane C., Vogel, Monique, Bachmann, Martin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161069/ https://www.ncbi.nlm.nih.gov/pubmed/30004398 http://dx.doi.org/10.3390/vaccines6030037

Ejemplares similares

The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments
por: Bogani, Giorgio, et al.
Publicado: (2020)

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate
por: Liu, Xuelan, et al.
Publicado: (2021)

Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands—A Role for CCL2
por: Gomes, Ariane C., et al.
Publicado: (2019)

Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface
por: Wang, Dongliang, et al.
Publicado: (2018)

114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023)

Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
por: C. Gomes, Ariane, et al.
Publicado: (2019)

Exploiting the Yeast L-A Viral Capsid for the In Vivo Assembly of Chimeric VLPs as Platform in Vaccine Development and Foreign Protein Expression
por: Powilleit, Frank, et al.
Publicado: (2007)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Chimeric virus-like particles (VLPs) designed from shrimp nodavirus (MrNV) capsid protein specifically target EGFR-positive human colorectal cancer cells
por: Grataitong, Khwanthana, et al.
Publicado: (2021)

Trends on Human Norovirus Virus-like Particles (HuNoV-VLPs) and Strategies for the Construction of Infectious Viral Clones toward In Vitro Replication
por: Sion, Emilly, et al.
Publicado: (2023)

Immunogenicity and Protective Activity of Pigeon Circovirus Recombinant Capsid Protein Virus-Like Particles (PiCV rCap-VLPs) in Pigeons (Columba livia) Experimentally Infected with PiCV
por: Huang, Huai-Ying, et al.
Publicado: (2021)

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
por: Pushko, Peter, et al.
Publicado: (2020)

Direct activation of a bacterial innate immune system by a viral capsid protein
por: Zhang, Tong, et al.
Publicado: (2022)

Induction of Robust and Specific Humoral and Cellular Immune Responses by Bovine Viral Diarrhea Virus Virus-Like Particles (BVDV-VLPs) Engineered with Baculovirus Expression Vector System
por: Wang, Zhanhui, et al.
Publicado: (2021)

Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate
por: Saraswat, Shweta, et al.
Publicado: (2016)

SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform
por: Hirschberg, Stefan, et al.
Publicado: (2022)

Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co‐delivered with norovirus VLPs
por: Malm, M., et al.
Publicado: (2017)

Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses
por: Menon, Ipshita, et al.
Publicado: (2023)

Special Issue “Virus-Like Particle Vaccines”
por: Vogel, Monique, et al.
Publicado: (2020)

TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization
por: Chang, Xinyue, et al.
Publicado: (2022)

Photodynamic Therapy in Combination with the Hepatitis B Core Virus-like Particles (HBc VLPs) to Prime Anticancer Immunity for Colorectal Cancer Treatment
por: Hao, Yang, et al.
Publicado: (2022)

RNA: packaged and protected by VLPs
por: Fang, Po-Yu, et al.
Publicado: (2018)

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
por: Kang, Hae-Ji, et al.
Publicado: (2019)

High immunogenicity of virus-like particles (VLPs) decorated with Aeromonas salmonicida VapA antigen in rainbow trout
por: Yang, Jeong In, et al.
Publicado: (2023)

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2019)

Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles
por: Chang, Xinyue, et al.
Publicado: (2022)

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

TRIM5 is an innate immune sensor for the retrovirus capsid lattice
por: Pertel, Thomas, et al.
Publicado: (2011)

Virus-like particle vaccinology, from bench to bedside
por: Mohsen, Mona O., et al.
Publicado: (2022)

Packaging of actin into Ebola virus VLPs
por: Han, Ziying, et al.
Publicado: (2005)

Cellular origin of the viral capsid-like bacterial microcompartments
por: Krupovic, Mart, et al.
Publicado: (2017)

Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
por: Swanson, Jessica, et al.
Publicado: (2021)

Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development
por: Zak, Andrew J., et al.
Publicado: (2023)

Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector
por: Kingston, Natalie J., et al.
Publicado: (2023)

Baculovirus Capsid Display Potentiates OVA Cytotoxic and Innate Immune Responses
por: Molinari, Paula, et al.
Publicado: (2011)

Finite Temperature Phase Behavior of Viral Capsids as Oriented Particle Shells
por: Singh, Amit R., et al.
Publicado: (2020)

Functional RNAs: combined assembly and packaging in VLPs
por: Fang, Po-Yu, et al.
Publicado: (2017)

Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography
por: Huhti, L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0adphltvtsplb7o87ej6u2lsrg